◆ 会议时间:2025年5月9-11日 ◆ 会议地点:阿联酋 迪拜
◆ 会议简介:
2025年第21届阿联酋重症医学大会(ECCC2025)将于2025年5月9-11日在阿联酋迪拜举行,本次会议由国际泛阿拉伯重症医学会(IPACCMS)、阿联酋重症医学会(EICS)等单位联合举办。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)
21st Emirates Critical Care Conference (ECCC 2025)
Dates: 9-11 May 2025 Venue: Intercontinental Hotel, Event Centre, Dubai Festival City, UAE
摘要征文投稿:
Abstract Submission Process
Please note, only Poster Abstracts are accepted for the Abstract submission for 2025. Abstracts must be submitted before 1 April 2025 (23:59 GMT) Notification on Acceptance/ Rejection: 15 April 2025. Abstracts must be submitted in English. Any withdrawal of abstracts should be through email response within 10 days of the acceptance notification email.
All accepted Poster Abstract presenters must register to attend the conference and bear all travel and accommodation expenses.
You will be asked to provide author names and affiliations in the online submission form (authors must be listed in order of involvement). Please do not include this information on your abstract content.
B. Presenting author and registration The presenting author of Poster Presenter must register as an active participant at the conference within 14 days after acceptance notification of an abstract is sent. All abstract presenters can avail a special 50% discount of the ongoing registration rate to register for the 3-day conference. ECCC Dubai 2025 reserves the right to exclude any abstract from the scientific program that is not followed by a participant registration within 14 days of acceptance notification. C. Contents of your abstract The abstract word limit is max. 300 words per abstract. ECCC Dubai 2025 Conference Secretariat reserves the right to edit abstracts that exceed the word limit. The title should be as brief as possible but long enough to clearly indicate the nature of the study. Write the abstract Title in CAPITAL LETTERS. No full stop at the end. All Abstracts to be submitted in word document format. No identifying features such as names of authors, hospitals, medical schools, clinics or cities may be listed in the title or abstract text, as a “blind” review process will be used. Please enter the author(s), Co-Author(s) and their institution(s) names correctly for certification purposes when you submit your abstract online. The abstract must include the following: Background Aim: Clearly state the purpose of the abstract. Methods: Describe your selection of observations or experimental subjects clearly. Results/Findings: Present your results in a logical sequence in text, table and illustrations. Conclusions: Emphasize new and important aspects of the study (perhaps as a discussion section) and the conclusions that are drawn from them. All abbreviations must be defined in first use. Statements such as “results will be discussed” or “data will be presented” cannot be accepted. Use of brand names on abstracts: For all references to products or companies, generic names must be used. The brand name can be inserted as a reference at the bottom of the abstract page. Papers containing brand names/company names in the abstract text (i.e. not in a reference at the bottom of the page) may be rejected for this reason only. ECCC Dubai 2025 reserves the right to replace any brand name with a generic name without further notice. Images that are uploaded to follow the abstract are only for the purpose of reviewing.
|